Can Fite Biopharma Ltd ADR Net Asset Quality Index
Can Fite Biopharma Ltd ADR net asset quality index. Can Fite Biopharma Ltd ADR (CANF) has a Net Asset Quality Index of 58.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $9.51 Million minus total liabilities of $3.92 Million yields net assets of $5.59 Million. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Can Fite Biopharma Ltd ADR for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Can Fite Biopharma Ltd ADR (2011–2025)
Net asset quality index of Can Fite Biopharma Ltd ADR from 2011 to 2025. This chart shows how Can Fite Biopharma Ltd ADR's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the index stands at 58.8%, representing net assets of $5.59 Million against total assets of $9.51 Million USD. Check Can Fite Biopharma Ltd ADR (CANF) strategic investment index to assess the company's strategic physical and investment asset allocation.
Can Fite Biopharma Ltd ADR Net Asset Quality Index by Year (2011–2025)
Can Fite Biopharma Ltd ADR net asset quality index by year from 2011 to 2025. The table below presents the year-by-year Net Asset Quality Index for Can Fite Biopharma Ltd ADR from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Can Fite Biopharma Ltd ADR stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 58.8% | $5.59 Million | $9.51 Million | $3.92 Million | ▼ -0.8 pp |
| 2024 | 59.6% | $5.44 Million | $9.12 Million | $3.68 Million | ▼ -2.9 pp |
| 2023 | 62.5% | $6.24 Million | $9.99 Million | $3.75 Million | ▲ +14.3 pp |
| 2022 | 48.2% | $4.47 Million | $9.28 Million | $4.81 Million | ▼ -22.8 pp |
| 2021 | 71.0% | $14.38 Million | $20.25 Million | $5.87 Million | ▲ +7.2 pp |
| 2020 | 63.8% | $6.07 Million | $9.52 Million | $3.45 Million | ▲ +33.9 pp |
| 2019 | 29.9% | $2.44 Million | $8.17 Million | $5.73 Million | ▼ -8.0 pp |
| 2018 | 37.9% | $3.02 Million | $7.95 Million | $4.94 Million | ▼ -1.1 pp |
| 2017 | 39.0% | $3.05 Million | $7.83 Million | $4.78 Million | ▲ +0.9 pp |
| 2016 | 38.1% | $3.87 Million | $10.17 Million | $6.29 Million | ▼ -21.2 pp |
| 2015 | 59.3% | $10.44 Million | $17.60 Million | $7.16 Million | ▼ -8.0 pp |
| 2014 | 67.3% | $6.86 Million | $10.19 Million | $3.33 Million | ▲ +0.1 pp |
| 2013 | 67.2% | $4.46 Million | $6.63 Million | $2.18 Million | ▲ +110.5 pp |
| 2012 | -43.3% | $-707.99K | $1.64 Million | $2.34 Million | ▼ -110.4 pp |
| 2011 | 67.1% | $3.29 Million | $4.90 Million | $1.61 Million | — |